Sign In

Login

Password

Forgot Password ? Sign Up

Bupropion (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Bupropion" in French language version.

refsWebsite
Global rank French rank
18nih.gov
4th place
12th place
15doi.org
2nd place
3rd place
2prescrire.org
low place
2,283rd place
1qmul.ac.uk
1,735th place
168th place
1sante.gouv.fr
low place
1,498th place
1web.archive.org
1st place
1st place
1wikiwix.com
194th place
17th place
1archive.is
87th place
20th place
1googleusercontent.com
243rd place
21st place
1drugtopics.com
low place
low place
1issn.org
57th place
4th place
1sciencedirect.com
149th place
80th place
1justice.gov
918th place
2,135th place
1cite-sciences.fr
low place
3,254th place
1sante.fr
8,603rd place
517th place
1psychiatriefes.org
low place
low place
1findarticles.com
424th place
818th place
1fda.gov
447th place
1,409th place
1europa.eu
68th place
67th place

archive.is

cite-sciences.fr

doi.org

dx.doi.org

  • (en) « Crises d’épilepsie induites par le bupropion », Revue Neurologique, vol. 160, nos 6-7,‎ , p. 701–703 (ISSN 0035-3787, DOI 10.1016/S0035-3787(04)71021-8, lire en ligne, consulté le ).
  • (en) Serretti A, Chiesa A, « Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis », J Clin Psychopharmacol, vol. 29, no 3,‎ , p. 259–66 (PMID 19440080, DOI 10.1097/JCP.0b013e3181a5233f)
  • (en) Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE, Fava M., « The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists », Ann Clin Psychiatry, vol. 14, no 3,‎ , p. 143–7 (PMID 12585563, DOI 10.1023/A:1021137118956)
  • (en) Masand PS, Ashton AK, Gupta S, Frank B, « Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study », Am J Psychiatry, vol. 158, no 5,‎ , p. 805–807 (PMID 11329407, DOI 10.1176/appi.ajp.158.5.805)
  • (en) DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E, « A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction », J Clin Psychiatry, vol. 66, no 7,‎ , p. 844–8 (PMID 16013899, DOI 10.4088/JCP.v66n0706)
  • (en) Ashton AK, Rosen RC, « Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction », J Clin Psychiatry, vol. 59, no 3,‎ , p. 112–5 (PMID 9541153, DOI 10.4088/JCP.v59n0304)
  • (en) Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL., « A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction », J Clin Psychiatry, vol. 65, no 1,‎ , p. 62–7 (PMID 14744170, DOI 10.4088/JCP.v65n0110)
  • (en) Crenshaw TL, Goldberg JP, Stern WC., « Pharmacologic modification of psychosexual dysfunction », J Sex Marital Ther, vol. 13, no 4,‎ , p. 239–52 (PMID 3121861, DOI 10.1080/00926238708403896)
  • (en) Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A, « Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women », J Sex Marital Ther, vol. 27, no 3,‎ , p. 303–16 (PMID 11354935, DOI 10.1080/009262301750257155)
  • (en) Segraves RT, Clayton A, Croft H, Wolf A, Warnock J., « Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women », J Clin Psychopharmacol, vol. 24, no 3,‎ , p. 339–42 (PMID 15118489, DOI 10.1097/01.jcp.0000125686.20338.c1)
  • (en) Mathias C, Cardeal Mendes CM, Ponde de Sena E, Dias de Moraes E, Bastos C, Braghiroli MI, Nunez G, Athanazio R, Alban L, Moore HC, del Giglio A., « An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer », Ann Oncol, vol. 17, no 12,‎ , p. 1792–6 (PMID 16980597, DOI 10.1093/annonc/mdl304)
  • (en) Modell JG, May RS, Katholi CR., « Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study », J Sex Marital Ther, vol. 26, no 3,‎ , p. 231–40 (PMID 10929571, DOI 10.1080/00926230050084623)
  • (en) Labbate LA, Brodrick PS, Nelson RP, Lydiard RB, Arana GW, « Effects of bupropion sustained-release on sexual functioning and nocturnal erections in healthy men », J Clin Psychopharmacol, vol. 21, no 1,‎ , p. 99–103 (PMID 11199957, DOI 10.1097/00004714-200102000-00018)
  • (en) Maneeton, N., Maneeton, B., Intaprasert, S., & Woottiluk, P., « A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder », Neuropsychiatric Disease and Treatment,‎ (PMID 25120365, DOI 10.2147/NDT.S62714)
  • (en) Ng Qin Xiang, « A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents », Journal of Child and Adolescent Psychopharmacology,‎ (PMID 27813651, DOI 10.1089/cap.2016.0124)

drugtopics.com

  • (en) « The bupropion prescriptions were calculated as a total of prescriptions for Wellbutrin XL, Budeprion XL, Budeprion SR, Bupropion SR and Bupropion ER using data from the charts for generic and brand-name drugs, see: » (en) « Top 200 Generic Drugs by Units in 2007 » [PDF], Drug Topics, (consulté le ) and (en) Verispan, « Top 200 Brand Drugs by Units in 2007 » [PDF], Drug Topics, (consulté le )

europa.eu

ema.europa.eu

fda.gov

findarticles.com

  • (en) Cabello F., « Effectiveness of the Treatment of Female Hypoactive Sexual Desire Disorder », J Sex Research,‎ (lire en ligne, consulté le )

googleusercontent.com

webcache.googleusercontent.com

issn.org

portal.issn.org

justice.gov

nih.gov

ncbi.nlm.nih.gov

  • (en) Jorenby D E, Hays J T, Rigotti N A, Azoulay S, Watsky E J, Williams K E, Billing C B, Gong J, Reeves K R, « Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial », JAMA, vol. 296, no 1,‎ , p. 56–63 (PMID 16820547) :

    « For weeks 9 through 52, 23% of participants in the varenicline group were continuously abstinent compared with 10.3% in the placebo group and 14.6% in the bupropion SR group. »

  • (en) [No authors listed] « Bupropion: congenital heart defects (continued) » Prescrire Int. 2012;21(126):97. PMID 22515134
  • (en) Serretti A, Chiesa A, « Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis », J Clin Psychopharmacol, vol. 29, no 3,‎ , p. 259–66 (PMID 19440080, DOI 10.1097/JCP.0b013e3181a5233f)
  • (en) Dording CM, Mischoulon D, Petersen TJ, Kornbluh R, Gordon J, Nierenberg AA, Rosenbaum JE, Fava M., « The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists », Ann Clin Psychiatry, vol. 14, no 3,‎ , p. 143–7 (PMID 12585563, DOI 10.1023/A:1021137118956)
  • (en) Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, Lineberry CG, « Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion », J Clin Psychiatry, vol. 54, no 12,‎ , p. 459–65 (PMID 8276736)
  • (en) Dobkin RD, Menza M, Marin H, Allen LA, Rousso R, Leiblum SR, « Bupropion improves sexual functioning in depressed minority women: an open-label switch study », J Clin Psychiatry, vol. 26, no 1,‎ , p. 21–6 (PMID 16415700)
  • (en) Masand PS, Ashton AK, Gupta S, Frank B, « Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study », Am J Psychiatry, vol. 158, no 5,‎ , p. 805–807 (PMID 11329407, DOI 10.1176/appi.ajp.158.5.805)
  • (en) DeBattista C, Solvason B, Poirier J, Kendrick E, Loraas E, « A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction », J Clin Psychiatry, vol. 66, no 7,‎ , p. 844–8 (PMID 16013899, DOI 10.4088/JCP.v66n0706)
  • (en) Ashton AK, Rosen RC, « Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction », J Clin Psychiatry, vol. 59, no 3,‎ , p. 112–5 (PMID 9541153, DOI 10.4088/JCP.v59n0304)
  • (en) Clayton AH, Warnock JK, Kornstein SG, Pinkerton R, Sheldon-Keller A, McGarvey EL., « A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction », J Clin Psychiatry, vol. 65, no 1,‎ , p. 62–7 (PMID 14744170, DOI 10.4088/JCP.v65n0110)
  • (en) Crenshaw TL, Goldberg JP, Stern WC., « Pharmacologic modification of psychosexual dysfunction », J Sex Marital Ther, vol. 13, no 4,‎ , p. 239–52 (PMID 3121861, DOI 10.1080/00926238708403896)
  • (en) Segraves RT, Croft H, Kavoussi R, Ascher JA, Batey SR, Foster VJ, Bolden-Watson C, Metz A, « Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women », J Sex Marital Ther, vol. 27, no 3,‎ , p. 303–16 (PMID 11354935, DOI 10.1080/009262301750257155)
  • (en) Segraves RT, Clayton A, Croft H, Wolf A, Warnock J., « Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women », J Clin Psychopharmacol, vol. 24, no 3,‎ , p. 339–42 (PMID 15118489, DOI 10.1097/01.jcp.0000125686.20338.c1)
  • (en) Mathias C, Cardeal Mendes CM, Ponde de Sena E, Dias de Moraes E, Bastos C, Braghiroli MI, Nunez G, Athanazio R, Alban L, Moore HC, del Giglio A., « An open-label, fixed-dose study of bupropion effect on sexual function scores in women treated for breast cancer », Ann Oncol, vol. 17, no 12,‎ , p. 1792–6 (PMID 16980597, DOI 10.1093/annonc/mdl304)
  • (en) Modell JG, May RS, Katholi CR., « Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study », J Sex Marital Ther, vol. 26, no 3,‎ , p. 231–40 (PMID 10929571, DOI 10.1080/00926230050084623)
  • (en) Labbate LA, Brodrick PS, Nelson RP, Lydiard RB, Arana GW, « Effects of bupropion sustained-release on sexual functioning and nocturnal erections in healthy men », J Clin Psychopharmacol, vol. 21, no 1,‎ , p. 99–103 (PMID 11199957, DOI 10.1097/00004714-200102000-00018)
  • (en) Maneeton, N., Maneeton, B., Intaprasert, S., & Woottiluk, P., « A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder », Neuropsychiatric Disease and Treatment,‎ (PMID 25120365, DOI 10.2147/NDT.S62714)
  • (en) Ng Qin Xiang, « A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents », Journal of Child and Adolescent Psychopharmacology,‎ (PMID 27813651, DOI 10.1089/cap.2016.0124)

prescrire.org

psychiatriefes.org

qmul.ac.uk

chem.qmul.ac.uk

sante.fr

ansm.sante.fr

sante.gouv.fr

agmed.sante.gouv.fr

sciencedirect.com

web.archive.org

wikiwix.com

archive.wikiwix.com